InvestorsHub Logo
icon url

PlentyParanoid

10/24/18 4:45 PM

#246254 RE: oddone33320 #246247

I agree in this sense: at this stage BTD would tell a possible partner a lot about FDA's attitude towards brilacidin in OM. BTD itself probably would have only a minor effect on phase 3 trial design. For that phase design rules tend to be ironclad.